This review summarizes the most up-to-date approach to the multidisciplinary management of patients with breast cancer brain metastases.
Amanda E. D. Van Swearingen, PhD
Advertisement
Articles by Amanda E. D. Van Swearingen, PhD
Approaches for Optimal Drug Development and Clinical Trial Design for Breast Cancer Brain Metastasis
Brain metastases arising from breast cancer constitute a clinically unmet need and a situation that portends a poor prognosis with few therapeutic options.
Advertisement
Latest Updated Articles
- Approaches for Optimal Drug Development and Clinical Trial Design for Breast Cancer Brain Metastasis
Published: July 15th 2014 | Updated:
Multidisciplinary Management of Breast Cancer Brain MetastasesPublished: October 15th 2016 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Updated Cosibelimab Label in Cutaneous Squamous Cell Carcinoma
2
FDA Approves Novel Blood-Based Prostate Cancer Test for Elevated PSA Levels
3
Subcutaneous Toripalimab Meets Primary End Points in Nonsquamous NSCLC
4
Zanidatamab Shows Meaningful Benefit in HER2+ Biliary Tract Cancer
5
